iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$14.71 USD
-0.27 (-1.77%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $14.69 -0.02 (-0.14%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
iTeos Therapeutics, Inc. [ITOS]
Reports for Purchase
Showing records 101 - 113 ( 113 total )
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Will ITOS Show Best-In-Class Anti-TIGIT Monotherapy Data at AACR?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
2Q20 Earnings; Data Updates for Lead Programs on Track for 1H21
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D